BridgeMD
Prevention study for Central-line Associated Blood Stream Infections (CLABSI)
Official title CLABSI Prevention With Tissue Adhesive
ClinicalTrials.gov ID: NCT05721677
What this study is testing
- What it's testing
- Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 18
You may be able to join if
- All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):
- young age\<1y \& Congenital Heart Surgery Mortality Category (STAT\\STS-EACTS) score 2-5
- Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
- preoperative length-of-stay (LOS) \>7 days
- preoperative ventilator support
You likely can't join if
- Patients with on-going bacteremia
- patients with pre-existing central-line or peripherally inserted central catheter (PICC)
- parental refusal to participate.
See the full eligibility criteria
- All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):
- young age\<1y \& Congenital Heart Surgery Mortality Category (STAT\\STS-EACTS) score 2-5
- Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
- preoperative length-of-stay (LOS) \>7 days
- preoperative ventilator support
- presence of a genetic abnormality
- extracorporeal membrane oxygenation (ECMO) support
- Patients with on-going bacteremia
- patients with pre-existing central-line or peripherally inserted central catheter (PICC)
- parental refusal to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Petah Tikva, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Petah Tikva, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.